|
Apr 3
|
Why Eli Lilly Stock Topped the Market Today
|
|
Apr 3
|
Verve (VERV) Pauses Enrollment in Cholesterol Study, Stock Falls
|
|
Apr 3
|
Lilly's weight-loss drug Zepbound to face supply crunch through April-end, US FDA says
|
|
Apr 3
|
UPDATE 2-Lilly's weight-loss drug Zepbound to face supply crunch through April-end, US FDA says
|
|
Apr 3
|
Dow Jones Futures: Market Rally Holds Support, Meta Near Buy Point; Tesla Skid Continues
|
|
Apr 2
|
Eli Lilly (LLY) Ascends While Market Falls: Some Facts to Note
|
|
Apr 2
|
Stocks Bend As Yields Rise; Meta Platforms, Uber, Eli Lilly In Focus
|
|
Apr 2
|
Some doses of Lilly's Mounjaro in tight supply through April, US FDA says
|
|
Apr 2
|
UPDATE 1-Some doses of Lilly's Mounjaro in tight supply through April, US FDA says
|
|
Apr 2
|
FDA website shows limited availability of some doses of Lilly's Mounjaro through April
|
|
Feb 14
|
UPDATE 1-Britain sees launch of Lilly's weight-loss drug Mounjaro
|
|
Feb 14
|
Britain sees launch of Lilly's weight-loss drug Mounjaro
|
|
Feb 14
|
Obesity-Drug Developer Altimmune Sinks on Short-Seller Report
|
|
Feb 14
|
3 Perfect Stocks to Buy This Valentine's Day
|
|
Feb 14
|
Amgen Takes Aim at Novo Nordisk and Eli Lilly, but Is the Stock a Buy?
|
|
Feb 13
|
Power Trader Challenges Texas Grid Policy Over Price Spikes
|
|
Feb 13
|
FDA warns online vendors selling misbranded weight-loss, diabetes drugs
|
|
Feb 13
|
Incyte's (INCY) Q4 Earnings & Revenues Fall Shy of Estimates
|
|
Feb 13
|
Eli Lilly partner BioAge raises $170 mln for obesity treatment
|
|
Feb 13
|
Move Aside, Eli Lilly and Novo Nordisk. Wall Street Thinks This Stock Will Be a Bigger Winner Over the Next 12 Months.
|